Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • News
  • Reiteration
  • Trading Ideas

Analyst Assess Implications of Bristol Myers’ Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence

By Vandana Singh
Yesterday, 2:58 PM
Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF) 

BAYRY

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • Media
  • News

Bayer’s Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details

By Vandana Singh
Yesterday, 1:34 PM
Bayer AG (OTC: BAYRY) (OTC: BAYZF) 

BAYRY

Read More
1 minute read
  • Biotech
  • Contracts
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is Depression Focused MIRA Pharmaceuticals Stock Trading Higher Today?

By Vandana Singh
Yesterday, 12:08 PM
MIRA Pharmaceuticals Inc (NASDAQ: MIRA) announced a partnership with MIRALOGX, LLC, an intellectual property holding company 

JNJ

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is Neuro-Oncology-Focused MediciNova Stock Trading Higher Today?

By Vandana Singh
Yesterday, 12:01 PM
MediciNova Inc's (NASDAQ: MNOV) collaborators presented new data and results of a Phase 2 clinical trial of MN-166 (ibudilast) in glioblastoma (GBM) patients at the Annual Meeting of the 

MNOV

Read More
2 minute read
  • General
  • Guidance
  • Health Care
  • Legal
  • Movers
  • News
  • Penny Stocks

Why Is Life Science Company NanoString Stock Trading Lower Today?

By Vandana Singh
Yesterday, 11:29 AM
NanoString Technologies Inc (NASDAQ: NSTG) shares are trading lower after a jury in the U.S.

NSTG

Read More
1 minute read
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is AI-Based Heart Disease Focused Cardio Diagnostics Stock Trading Higher Today?

By Vandana Singh
Yesterday, 11:19 AM
Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) announced the publication of its study in the Journal of the American Heart Association (JAHA), an official journal of the 

CDIO

Read More
1 minute read
  • Biotech
  • Equities
  • FDA
  • General
  • Health Care
  • Large Cap
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is Pharma Giant Bristol-Myers Squibb Stock Trading Lower Today?

By Vandana Singh
Yesterday, 9:37 AM
Shares of Bristol-Myers Squibb Company (NYSE: BMY) and  2seventy Bio Inc (NASDAQ: TSVT) fell after the companies' efforts to win expanded U.S.

BMY

Read More
1 minute read
  • Equities
  • FDA
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

FDA Approves Medtronic’s Hypertension Device Despite Initial Doubts From Adcomm Panel

By Vandana Singh
Yesterday, 7:57 AM
Friday, the FDA approved Medtronic plc's (NYSE: MDT) Symplicity Spyral renal denervation (RDN) system, also known as the Symplicity blood pressure procedure, for hypertension or 

MDT

Read More
1 minute read
  • Biotech
  • Equities
  • Exclusives
  • General
  • Health Care
  • Markets
  • News
  • Penny Stocks

EXCLUSIVE: Alzamend Neuro Receives FDA Go-Ahead Letter For Mid-Stage Major Depressive Disorder Study

By Vandana Singh
Yesterday, 7:30 AM
Alzamend Neuro Inc (NASDAQ: ALZN) has received a "Study May Proceed" letter from the FDA for the initiation of study AL001-MDD01, a Phase 2A clinical study of AL001 for 

ALZN

Read More
2 minute read
  • Equities
  • FDA
  • General
  • Health Care
  • Markets
  • News

Merck’s Latest Drug For Chronic Cough Faces FDA Pushback

By Nabaparna Bhattacharya
November 18, 2:21 PM
A panel of advisors to the Food and Drug Administration (FDA) reportedly expressed concerns about the efficacy of Merck & Company, Inc.'s (NYSE:

GSK

Posts pagination

Previous 1 … 114 115 116 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service